2-Amino-4-Thiazolecarboxylic Acid Ethyl Ester

Synthesis of (Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic Acid Ethyl Ester (ATMO Ethyl Ester)

Production of the critical cephalosporin side-chain precursor ATMO ethyl ester proceeds via a two‑stage condensation–oximation pathway conducted under strictly anhydrous conditions. Ethyl 2‑amino‑4‑thiazolecarboxylate, assayed against an in‑house HPLC method calibrated using BP/EP chemical reference substances, is dissolved in dichloromethane dried over molecular sieves (3 Å, residual water < 50 ppm by Karl Fischer). Triethylamine (1.10 mol eq.) is added as acid scavenger, and the solution cooled to −10 °C in a glass‑lined reactor (Pfaudler AE 40 glass, jacket service fluid Syltherm XLT). (Z)‑2‑Methoxyiminoacetyl chloride, freshly prepared and assayed at ≥ 98.0 % acyl chloride content, is metered via a mass flow controller at a rate that maintains the internal temperature at −8 °C to −5 °C; the mole ratio of acid chloride to ester is held at 1.05:1.00. After 45 min of post‑addition stirring, the batch is quenched into pre‑chilled deionised water (2 °C), the organic layer separated and washed with 5 % w/w sodium bicarbonate solution until the aqueous phase pH stabilises at 7.2‑7.5. The dichloromethane is distilled under reduced pressure (450 mbar, jacket ≤ 35 °C) and replaced with isopropanol to crystallise the product. The slurry is centrifuged through a horizontal peeler centrifuge (Heinkel HZ 630), washed with chilled isopropanol, and dried in a double‑cone rotary vacuum dryer at 40 °C/20 mbar to a loss‑on‑drying end point of < 0.5 %. The isolated ATMO ethyl ester exhibits a white to off‑white crystalline appearance, melting range 122‑124 °C, and an HPLC purity profile with single‑impurity limits conforming to ICH Q3A thresholds: any unspecified impurity ≤ 0.10 %, total impurities ≤ 0.50 %. Residual solvents are controlled per ICH Q3C Option‑1 limits (dichloromethane ≤ 600 ppm, isopropanol ≤ 5000 ppm). This intermediate fulfils the EP general monograph for “Substances for Pharmaceutical Use” (2034) and is shipped under full REACH (EC) No 1907/2006 registration with an allowable tonnage band matched to the annual synthesis volume of downstream sterile cephalosporins.

Ceftazidime pentahydrate manufacturing campaigns conducted in a 500 L glass‑lined reactor train utilise ethyl 2‑amino‑4‑thiazolecarboxylate as the chemical precursor that is first converted to activated (Z)‑2‑(2‑aminothiazol‑4‑yl)‑2‑methoxyiminoacetic acid (ATMO acid) through saponification of the ethyl ester with lithium hydroxide in aqueous tetrahydrofuran at 5 °C. On the plant floor, a single batch of ceftazidime pentahydrate sterile powder is typically initiated by charging 65.0 kg of ATMO acid (dry basis) into the acylation vessel containing 46.2 kg of 7‑amino‑3‑(1‑pyridiniummethyl)‑3‑cephem‑4‑carboxylate dihydrochloride (7‑APCA), suspended in 290 L of anhydrous N,N‑dimethylacetamide with 3.4 kg of triethylamine. The active ester is prepared in a separate loop by reacting the ATMO acid with ethyl chloroformate in the presence of N‑methylmorpholine at −15 °C; complete conversion of the carboxylic acid to the mixed anhydride is confirmed by in‑line ReactIR monitoring of the carbonyl stretching frequency shift from 1740 cm⁻¹ to 1825 cm⁻¹. Coupling is performed by transferring the pre‑cooled active ester solution via jacketed PTFE‑lined transfer lines into the 7‑APCA slurry, maintaining the reaction mass at −20 °C for 120 min. The mole ratio of activated side‑chain to nucleus is controlled at 1.08:1.00; excess acylating agent is deliberately employed because the crystalline ceftazidime pentahydrate particle habit—critical for sterile micronisation—is highly sensitive to residual un‑reacted 7‑APCA, which can induce amorphous zones detectable by X‑ray powder diffractometry (XRPD) and correlated to a reduction in the D₉₀ particle size from 45 µm to 12 µm during jet milling. After aqueous work‑up and pH‑adjusted crystallisation at pH 3.8 using 2 M hydrochloric acid, the wet crystal cake is washed with a water/acetone mixture and dried in a Guedu agitated vacuum dryer to a moisture content ≤ 4.5 % (the defined stoichiometric pentahydrate window). The finished product meets the Ph. Eur. Ceftazidime Pentahydrate monograph 01/2021:1402 on related substances, with the content of the Δ‑3‑isomer impurity restricted to ≤ 0.8 %. Table 1 summarises the correlation between the starting ethyl ester purity profile and the downstream isomer load in the final injectable drug substance, as captured on a Shimadzu LC‑40 system using a C‑18 column (4.6 × 250 mm, 5 µm) with UV detection at 254 nm.

Why Does Residual Acetyl Chloride in the Starting Ester Compromise Aztreonam Monobactam Ring Closure?

During the synthesis of aztreonam, the monocyclic β‑lactam nucleus (3‑azido‑4‑methyl‑2‑oxoazetidine‑1‑sulfonate) is acylated with the identical (Z)‑2‑(2‑aminothiazol‑4‑yl)‑2‑methoxyiminoacetic acid side‑chain; however, the single‑ring geometry exhibits markedly greater sensitivity to electrophilic impurities carried over from the ethyl 2‑amino‑4‑thiazolecarboxylate feedstock. In a standard campaign operated in a 200 L Hastelloy C‑22 reactor, exactly 18.7 kg of the ethyl ester— having a residual acetyl chloride content determined by headspace GC‑MS (Agilent 7890B / 5977A, quantitation ion m/z 43) below 12 ppm—is transformed to the mixed anhydride with ethyl chloroformate in the presence of N‑methylmorpholine. The activated species is subsequently united with the azetidinone nucleus at −40 °C in dichloromethane; the stoichiometric ratio of active ester to nucleus is tightly maintained at 1.03:1.00. If the incoming acetyl chloride concentration exceeds the 20 ppm action threshold, acetylation of the azetidinone N‑1 position competes with the desired amidine ring formation, leading to an isolable by‑product identified by LC‑QTOF (retention time shift +1.24 min, [M+H]⁺ = 412.1038) that co‑crystallises with the target molecule during the final ethanol‑water recrystallisation. Process analytical technology (PAT) data from 12 consecutive production batches shows that when the ethyl ester acetyl chloride level is held at ≤ 10 ppm, the aztreonam monohydrate yield after Class 8 cleanroom isolation reaches 86‑89 % of theory, with the total impurity profile complying with the USP Aztreonam monograph <1640> (crystallinity confirmed by Raman spectroscopy peak at 1778 cm⁻¹). The final product is packed as sterile crystalline powder in 10 kg aluminium composite containers under a laminar airflow unit (cGMP Grade B/A) and released with endotoxin levels below 0.03 EU/mg, meeting ICH M7 control strategy for mutagenic impurities originating from the thiazole ring‑forming sequence.

When palladium content from hydrogenolysis steps must be controlled to < 10 ppm in ceftriaxone sodium sterile powder, the entire manufacturing chain—starting from the sourcing of ethyl 2‑amino‑4‑thiazolecarboxylate—undergoes stringent process hazard analysis. In a 1000 L dedusted reactor suite, 98.5 kg of the ester is saponified with sodium hydroxide in methanol/water (3:1 v/v) to generate the sodium salt of ATMO acid, which is then acidified and precipitated to obtain the free acid of EP reference grade (chromatographic purity ≥ 99.7 %). This acid is activated by conversion to the thioester with 2,2′‑dithiobis(benzothiazole) in dimethylacetamide containing 1.5 % w/w pyridine. The activated thioester (1.15 mol eq. relative to the amino nucleus) is coupled with 7‑amino‑3‑[(2,5‑dihydro‑6‑hydroxy‑2‑methyl‑5‑oxo‑1,2,4‑triazin‑3‑yl)thiomethyl]‑3‑cephem‑4‑carboxylic acid (7‑ACT) in a water/acetone mixture at 0 °C to 3 °C over 4 h while the pH is maintained at 6.8‑7.2 by automated dosing of 20 % w/w triethylamine solution. The addition ratio is critical: an excess of thioester above 1.25 mol eq. causes the formation of a di‑acylated impurity (relative retention time 2.33 versus ceftriaxone on a Ph. Eur. system suitability reference chromatogram) that cannot be adequately purged during the subsequent acetonitrile‑based crystallisation. The crystallised ceftriaxone sodium hemiheptahydrate is filtered through a Rosemund filter dryer under inert nitrogen blanket; drying is performed at 25 mbar with jacket temperature ramped from 25 °C to 35 °C over 8 h, reaching a final water content of 8.5‑10.0 % (Karl Fischer) as prescribed by the EP Ceftriaxone Sodium monograph 01/2021:0999. The sterile substance is filled into 15 kg amber glass vials under nitrogen and released for lyophilised‑powder compounding. Each batch is accompanied by a full elemental impurity testing report per ICH Q3D showing that the palladium concentration remains below the specified 10 ppm oral-concentration limit extrapolated for injectable administration, with a typical measured value of 3.2 ppm (ICP‑MS, Agilent 7900).

Low‑Temperature Diazotization and Subsequent Coupling onto N,N‑Diethyl‑m‑toluidine

Ethyl 2‑amino‑4‑thiazolecarboxylate serves as a primary aromatic amine‑based diazo component in the manufacture of monoazo disperse dyes that must meet the high‑wash‑fastness specifications required by OEKO‑TEX® Standard 100 classes I‑IV. The diazotization step is carried out in a rubber‑lined steel vessel of 3000 L capacity, where 78.0 kg of the dry aminoester (purity ≥ 98.5 %, melting point 101‑103 °C) is dissolved in 350 L of 85 % phosphoric acid and cooled with brine circulation to −2 °C. A chilled aqueous solution of sodium nitrite (1.02 mol eq., precisely 22.8 kg of NaNO₂ dissolved in 80 L demineralised water) is introduced below the liquid surface via a dip‑pipe over 75 min while the agitator tip speed is held constant at 2.5 m/s. The end point of diazotization is verified by starch‑iodide paper and further validated by an in‑line UV‑Vis probe that tracks the absorbance at 285 nm until a plateau indicates complete conversion of the aminoester to the diazonium salt. The resulting diazonium liquor is immediately coupled with N,N‑diethyl‑m‑toluidine (coupling component, 0.98 mol eq. relative to the original amine) dissolved in a 2:1 mixture of ice‑water and acetic acid. The coupling pH is maintained at 3.0‑3.5 by controlled addition of sodium acetate buffer to suppress triazene side reactions; the temperature is kept within a tight 0‑4 °C window using a secondary brine circuit. After 2 h of coupling, the precipitated dye is filtered on a filter press (membrane plates, 800 × 800 mm), washed until the filtrate conductivity falls below 100 µS/cm, and re‑slurried with a lignosulfonate dispersant at a 1:0.35 dye‑to‑dispersant weight ratio. The slurry is atomised in a counter‑current spray dryer (Niro F‑63, inlet air 210 °C, outlet air 85 °C) to produce a non‑dusting granular product of C.I. Disperse Red 153 (assigned by the ETAD colour index framework). The dye powder is assessed against ISO 105‑C06: 2010 (Test No. C2S, 5 g/L dyeing liquor); the staining on adjacent multifibre ribbon achieves a grade of 4‑5, and the light fastness determined by ISO 105‑B02: 2014 reaches blue wool scale 5. Under REACH Annex XVII entry 43, the final dye is certified free of restricted aromatic amines (ultra‑performance convergence chromatography–MS, LOD 0.5 mg/kg for each listed amine). The addition ratio and coupling pH optimised for this specific aminoester core are consolidated in Table 2, which correlates dyebath parameters with build‑up on polyester knitted fabric (PES interlock, 180 g/m², high‑temperature exhaust process at 130 °C).

For polyacrylonitrile dyeing operations requiring a migration index > 90 % and high‑lightfastness on outdoor‑use acrylics, ethyl 2‑amino‑4‑thiazolecarboxylate is converted to a quaternised styryl‑type basic dye through a three‑step sequence that does not tolerate moisture excursions. The ester is first condensed with p‑(N,N‑dimethylamino)benzaldehyde in refluxing piperidine‑catalysed ethanol at 80 °C for 6 h, yielding the intermediate styryl base that precipitates upon cooling and is filtered under nitrogen atmosphere (water absorption of this intermediate exceeds 1.2 % w/w within 20 min of ambient exposure, rendering subsequent quaternisation sluggish). The isolated base is suspended in 1,2‑dichloroethane and reacted with dimethyl sulfate (1.10 mol eq.) at 55 °C for 4 h in a sealed, vent‑plumbed reactor in which the oxygen content is maintained below 2 % v/v by continuous nitrogen purge, a necessary measure because the thiazolium methosulfate product catalyses peroxide formation. After quenching the excess dialkyl sulfate with aqueous ammonia, the cationic dye is precipitated as the zinc chloride double salt by the addition of 30 % w/w zinc chloride solution at 5 °C, centrifuged, and dried at 50 °C under 50 mbar vacuum. The product aligns with C.I. Basic Yellow 11 (CAS 12221‑48‑6) and is standardised with dextrin to a colour strength of 200 % relative to the un‑standardised presscake. Compliance testing references the ZDHC MRSL v 3.1 candidate list for basic dye auxiliaries; the regulated element screen (ICP‑MS after microwave digestion) shows mercury < 0.5 mg/kg, cadmium < 1 mg/kg, and hexavalent chromium below the 3 mg/kg detection threshold set by ISO 17075‑1: 2020. The addition level in a typical exhausted acrylic dyeing recipe ranges from 0.05 % to 0.30 % o.w.f. depending on target depth, and the thiazole‑based chromophore achieves a half‑dyeing time on Basacryl®‑type fibre of 8 min at 100 °C (Launder‑Ometer test), making the dye suitable for carrier‑free acrylic blends where differential migration must remain below 5 %.